Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - TOTAL EQUITY
Total Equity BIIB - Biogen Inc.
16.7 B
LAST VALUE
11.78%
2 YEAR CAGR
4.62%
5 YEAR CAGR
4.45%
10 YEAR CAGR